GILEAD SCIENCES, INC. bought XLO
April 2, 2024 · Form 4 insider transaction
GILEAD SCIENCES, INC. bought 485,250 shares of Xilio Therapeutics, Inc. at $0.76 per share, a transaction worth $368.8K. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
485,250
Price
$0.76
Total value
$368.8K
InsiderGILEAD SCIENCES, INC.
Role—
SecurityCommon Stock
Transaction codeP: Open-market purchase
Transaction dateApril 2, 2024
Filing dateApril 3, 2024
Shares owned after7,345,473
OwnershipDirect
10b5-1 planNo
AmendedNo